IGM Biosciences, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
IGMS on Nasdaq
Industry
Pharmaceutical Preparations
Location
325 E Middlefield Road, Mountain View, California

Insiders trading volume in the past year

IGM Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jakob Haldor Topsoe Director, 10%+ Owner $79.4M Jun 28, 2024
Redmile Group, LLC Director, 10%+ Owner $70.8M Jun 28, 2024
Holding A/S Topsoe 10%+ Owner $40.4M Jun 26, 2023
Baker Bros. Advisors Lp Director, 10%+ Owner $28.5M +$6.86M +31.7% Jun 28, 2024
Fred Schwarzer CEO AND PRESIDENT, Director $3.41M -$229K -6.3% Jun 14, 2024
Bruce Keyt Chief Scientific Officer $1.88M -$96.4K -4.87% Jul 19, 2024
William Strohl Director $1.75M Aug 8, 2024
Mary Beth Harler Head, Research & Autoimmunity $1.25M -$11.9K -0.94% Jul 19, 2024
Chris H. Takimoto Chief Medical Officer $1.18M -$73.5K -5.86% Jul 19, 2024
Misbah Tahir Chief Financial Officer $941K -$73.1K -7.21% Jul 19, 2024
Lisa Lynn Decker Chief Business Officer $855K -$73.8K -7.95% Jul 19, 2024
Daniel ShinYu Chen Chief Medical Officer $769K Jul 1, 2021
Christina Teng Topsoe Director, 10%+ Owner $425K Jun 28, 2024
M. Kathleen Behrens Director $325K Jun 28, 2024
George Gauthier Chief Commercial Officer $262K -$14.8K -5.34% Nov 29, 2023
Michael D. Loberg Director $231K Sep 29, 2023
Steven Weber Principal Accounting Officer $197K -$13.7K -6.5% Jun 14, 2024
Michael Lee Director $57.5K Jun 28, 2024
Julie Hambleton Director $28K -$212K -88.3% Jul 25, 2024
Elizabeth H.Z. Thompson Director $22K Jun 28, 2024

Recent Insider Transactions by Companies or Individuals for IGM Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.